{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:37:18Z","timestamp":1793497038954,"version":"4.5.0"},"reference-count":46,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_raon-2022-0038_s_009\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gestational trophoblastic disease (GTD) is a heterogeneous group of rare tumours characterised by abnormal proliferation of trophoblastic tissue. It consists of benign or premalignant conditions, such as complete and partial molar pregnancy and variants of malignant diseases. The malignant tumours specifically are commonly referred to as gestational trophoblastic neoplasia (GTN). They consist of invasive mole, choriocarcinoma, placental-site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2022-0038_s_010\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with GTD are often asymptomatic, although vaginal bleeding is a common presenting symptom. With the advances in ultrasound imaging in early pregnancy, the diagnosis of molar pregnancy is most commonly made in the first trimester of pregnancy. Sometimes, additional imaging such as chest X-ray, CT or MRI can help detect metastatic disease. Most women can be cured, and their reproductive function can be preserved. In this review, we focus on the advances in management strategies for gestational trophoblastic disease as well as possible future research directions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/raon-2022-0038","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T10:18:11Z","timestamp":1666779491000},"page":"430-439","source":"Crossref","is-referenced-by-count":51,"title":["Advances in diagnostics and management of gestational trophoblastic disease"],"prefix":"10.2478","volume":"56","author":[{"given":"Nusa","family":"Lukinovic","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Maribor , Maribor , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Pavla","family":"Malovrh","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Maribor , Maribor , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iztok","family":"Takac","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Maribor , Maribor , Slovenia"},{"name":"Divison of Gynecology and Perinatology, University Medical Centre Maribor , Maribor , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sobocan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Maribor , Maribor , Slovenia"},{"name":"Divison of Gynecology and Perinatology, University Medical Centre Maribor , Maribor , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Knez","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Maribor , Maribor , Slovenia"},{"name":"Divison of Gynecology and Perinatology, University Medical Centre Maribor , Maribor , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"2026071215153105417_j_raon-2022-0038_ref_001","doi-asserted-by":"crossref","unstructured":"Lok C, Frijstein M, van Trommel N. Clinical presentation and diagnosis of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol 2020; 74: 42-52. doi: 10.1016\/j.bpobgyn.2020.12.001","DOI":"10.1016\/j.bpobgyn.2020.12.001"},{"key":"2026071215153105417_j_raon-2022-0038_ref_002","doi-asserted-by":"crossref","unstructured":"Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet 2018; 143(Suppl 2): 79-85. doi: 10.1002\/ ijgo.12615","DOI":"10.1002\/ijgo.12615"},{"key":"2026071215153105417_j_raon-2022-0038_ref_003","doi-asserted-by":"crossref","unstructured":"Fehlmann A, Benkortbi K, Rosseel G, Meyer-Hamme U, Tille JC, Sloan-Bena F, et al. Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre. Swiss Med Wkly 2021; 151: w20406. doi: 10.4414\/smw.2021.20406","DOI":"10.4414\/smw.2021.20406"},{"key":"2026071215153105417_j_raon-2022-0038_ref_004","doi-asserted-by":"crossref","unstructured":"Capobianco G, Tinacci E, Saderi L, Dessole F, Petrillo M, Madonia M, et al. High incidence of gestational trophoblastic disease in a third-level university-hospital, Italy: a retrospective cohort study. Front Oncol 2021; 11: 684700. doi: 10.3389\/fonc.2021.684700","DOI":"10.3389\/fonc.2021.684700"},{"key":"2026071215153105417_j_raon-2022-0038_ref_005","doi-asserted-by":"crossref","unstructured":"Eysbouts YK, Bulten J, Ottevanger PB, Thomas CMG, ten Kate-Booij MJ, van Herwaarden AE, et al. Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study. Gynecol Oncol 2016; 140: 70-5. doi: 10.1016\/j.ygyno.2015.11.014","DOI":"10.1016\/j.ygyno.2015.11.014"},{"key":"2026071215153105417_j_raon-2022-0038_ref_006","unstructured":"Hancock BW, Seckl MJ, Berkowitz RS. Gestational trophoblastic disease. London: Hodder Education Publishers; 2022."},{"key":"2026071215153105417_j_raon-2022-0038_ref_007","doi-asserted-by":"crossref","unstructured":"Soper JT. Gestational trophoblastic disease: current evaluation and management. Obstet Gynecol 2021; 137: 355-70. doi: 10.1097\/ AOG.0000000000004240","DOI":"10.1097\/AOG.0000000000004240"},{"key":"2026071215153105417_j_raon-2022-0038_ref_008","doi-asserted-by":"crossref","unstructured":"Fisher RA, Maher GJ. Genetics of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol 2021; 74: 29-41. doi: 10.1016\/j.bpob-gyn.2021.01.004","DOI":"10.1016\/j.bpobgyn.2021.01.004"},{"key":"2026071215153105417_j_raon-2022-0038_ref_009","doi-asserted-by":"crossref","unstructured":"Kaur B. Pathology of gestational trophoblastic disease (GTD). Best Pract Res Clin Obstet Gynaecol 2021; 74: 3-28. doi: 10.1016\/j.bpobgyn.2021.02.005","DOI":"10.1016\/j.bpobgyn.2021.02.005"},{"key":"2026071215153105417_j_raon-2022-0038_ref_010","doi-asserted-by":"crossref","unstructured":"Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet 2010; 376: 717-29. doi: 10.1016\/S0140-6736(10)60280-2","DOI":"10.1016\/S0140-6736(10)60280-2"},{"key":"2026071215153105417_j_raon-2022-0038_ref_011","doi-asserted-by":"crossref","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Sook Chon H, et al. Gestational trophoblastic neoplasia, version 2.2019. J Natl Compr Canc Netw 2019; 17: 1374-91. doi: 10.6004\/jnccn.2019.0053","DOI":"10.6004\/jnccn.2019.0053"},{"key":"2026071215153105417_j_raon-2022-0038_ref_012","doi-asserted-by":"crossref","unstructured":"Lok C, van Trommel N, Massuger L, Golfier F, Seckl M. Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease. Eur J Cancer 2020; 130: 228-40. doi: 10.1016\/j.ejca.2020.02.011","DOI":"10.1016\/j.ejca.2020.02.011"},{"key":"2026071215153105417_j_raon-2022-0038_ref_013","doi-asserted-by":"crossref","unstructured":"Cavoretto P, Cioffi R, Mangili G, Petrone M, Bergamini A, Rabaiotti E, et al. A pictorial ultrasound essay of gestational trophoblastic disease. J Ultrasound Med 2020; 39: 597-613. doi: 10.1002\/jum.15119","DOI":"10.1002\/jum.15119"},{"key":"2026071215153105417_j_raon-2022-0038_ref_014","doi-asserted-by":"crossref","unstructured":"Memtsa M, Johns J, Jurkovic D, Ross JA, Sebire NJ, Jauniaux E. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2020; 253: 206-12. doi: 10.1016\/j.ejogrb.2020.07.030","DOI":"10.1016\/j.ejogrb.2020.07.030"},{"key":"2026071215153105417_j_raon-2022-0038_ref_015","doi-asserted-by":"crossref","unstructured":"Jauniaux E, Memtsa M, Johns J, Ross JA, Sebire NJ, Jurkovic D. Ultrasound diagnosis of complete and partial hydatidiform moles in early pregnancy failure: an inter-observer study. Placenta 2020; 97: 65-7. doi: 10.1016\/j. placenta.2020.06.013","DOI":"10.1016\/j.placenta.2020.06.013"},{"key":"2026071215153105417_j_raon-2022-0038_ref_016","doi-asserted-by":"crossref","unstructured":"Kirk E, Papageorghiou AT, Condous G, Bottomley C, Bourne T. The accuracy of first trimester ultrasound in the diagnosis of hydatidiform mole. Ultrasound Obstet Gynecol 2007; 29: 70-5. doi: 10.1002\/uog.3875","DOI":"10.1002\/uog.3875"},{"key":"2026071215153105417_j_raon-2022-0038_ref_017","doi-asserted-by":"crossref","unstructured":"Shaaban AM, Rezvani M, Haroun RR, Kennedy AM, Elsayes KM, Olpin JD, et al. Gestational trophoblastic disease: clinical and imaging features. Radiographics 2017; 37: 681-700. doi: 10.1148\/rg.2017160140","DOI":"10.1148\/rg.2017160140"},{"key":"2026071215153105417_j_raon-2022-0038_ref_018","doi-asserted-by":"crossref","unstructured":"Jauniaux E, Memtsa M, Johns J, Ross JA, Jurkovic D. New insights in the pathophysiology of complete hydatidiform mole. Placenta 2018; 62: 28-33. doi: 10.1016\/j.placenta.2017.12.008","DOI":"10.1016\/j.placenta.2017.12.008"},{"key":"2026071215153105417_j_raon-2022-0038_ref_019","doi-asserted-by":"crossref","unstructured":"Knez J, Day A, Jurkovic D. Ultrasound imaging in the management of bleeding and pain in early pregnancy. Best Pract Res Clin Obstet Gynaecol 2014; 28: 621-36. doi: 10.1016\/j.bpobgyn.2014.04.003","DOI":"10.1016\/j.bpobgyn.2014.04.003"},{"key":"2026071215153105417_j_raon-2022-0038_ref_020","doi-asserted-by":"crossref","unstructured":"Lin LH, Bernardes LS, Hase EA, Fushida K, Francisco RPV. Is Doppler ultrasound useful for evaluating gestational trophoblastic disease? Clinics 2015; 70: 810. doi: 10.6061\/clinics\/2015(12)08","DOI":"10.6061\/clinics\/2015(12)08"},{"key":"2026071215153105417_j_raon-2022-0038_ref_021","unstructured":"Taylor HS, Pal L, Seli E. Speroff\u2019s clinical gynecologic endocrinology and infertility. Philadelphia: Wolters Kluwer; 2020."},{"key":"2026071215153105417_j_raon-2022-0038_ref_022","doi-asserted-by":"crossref","unstructured":"McMahon LM, Stewart WW, Cuthill L. Human chorionic gonadotrophin assays to monitor GTD. Best Pract Res Clin Obstet Gynaecol 2021; 74: 109-21. doi: 10.1016\/j.bpobgyn.2021.05.001","DOI":"10.1016\/j.bpobgyn.2021.05.001"},{"key":"2026071215153105417_j_raon-2022-0038_ref_023","doi-asserted-by":"crossref","unstructured":"Sato A, Usui H, Shozu M. Comparison between vacuum aspiration and forceps plus blunt curettage for the evacuation of complete hydatidi-form moles. Taiwan J Obstet Gynecol 2019; 58: 650-5. doi: 10.1016\/j. tjog.2019.07.012","DOI":"10.1016\/j.tjog.2019.07.012"},{"key":"2026071215153105417_j_raon-2022-0038_ref_024","doi-asserted-by":"crossref","unstructured":"Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet 2021; 155: 86-93. doi: 10.1002\/ijgo.13877","DOI":"10.1002\/ijgo.13877"},{"key":"2026071215153105417_j_raon-2022-0038_ref_025","doi-asserted-by":"crossref","unstructured":"Tidy J, Seckl M, Hancock BW, on behalf of the Royal College of Obstetricians and Gynaecologists. Management of gestational trophoblastic disease. BJOG 2021; 128: e1-27. doi: 10.1111\/1471-0528.16266","DOI":"10.1111\/1471-0528.16266"},{"key":"2026071215153105417_j_raon-2022-0038_ref_026","doi-asserted-by":"crossref","unstructured":"Horowitz NS, Eskander RN, Adelman MR, Burke W. Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: a society of gynecologic oncology evidenced-based review and recommendation. Gynecol Oncol 2021; 163: 605-13. doi: 10.1016\/j.ygyno.2021.10.003","DOI":"10.1016\/j.ygyno.2021.10.003"},{"key":"2026071215153105417_j_raon-2022-0038_ref_027","doi-asserted-by":"crossref","unstructured":"Ngu SF, Ngan HYS. Surgery including fertility-sparing treatment of GTD. Best Pract Res Clin Obstet Gynaecol 2021; 74: 97-108. doi: 10.1016\/j. bpobgyn.2020.10.005","DOI":"10.1016\/j.bpobgyn.2020.10.005"},{"key":"2026071215153105417_j_raon-2022-0038_ref_028","doi-asserted-by":"crossref","unstructured":"Zhao P, Lu Y, Huang W, Tong B, Lu W. Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis. BMC Cancer 2019; 19: 13. doi: 10.1186\/s12885-018-5168","DOI":"10.1186\/s12885-018-5168-x"},{"key":"2026071215153105417_j_raon-2022-0038_ref_029","doi-asserted-by":"crossref","unstructured":"Gockley AA, Lin LH, Davis M, Melamed A, Rizzo A, Sun SY, et al. Impact of clinical characteristics on human chorionic gonadotropin regression after molar pregnancy. Clinics 2021; 76: e2830. doi: 10.6061\/clinics\/2021\/e2830","DOI":"10.6061\/clinics\/2021\/e2830"},{"key":"2026071215153105417_j_raon-2022-0038_ref_030","doi-asserted-by":"crossref","unstructured":"Eysbouts Y, Brouwer R, Ottevanger P, Massuger L, Sweep F, Thomas C, et al. Serum human chorionic gonadotropin normogram for the detection of gestational trophoblastic neoplasia. Int J Gynecol Cancer 2017; 27: 1035-41. doi: 10.1097\/IGC.0000000000000966","DOI":"10.1097\/IGC.0000000000000966"},{"key":"2026071215153105417_j_raon-2022-0038_ref_031","doi-asserted-by":"crossref","unstructured":"Snyman LC. Gestational trophoblastic disease: an overview. S Afr J Gynaecol Oncol 2009; 1: 32-7. doi: 10.1080\/20742835.2009.11441132","DOI":"10.1080\/20742835.2009.11441132"},{"key":"2026071215153105417_j_raon-2022-0038_ref_032","doi-asserted-by":"crossref","unstructured":"Lurain JR. Gestational trophoblastic tumors. Semin Surg Oncol 1990; 6: 347-53. doi: 10.1002\/SSU.2980060610","DOI":"10.1002\/ssu.2980060610"},{"key":"2026071215153105417_j_raon-2022-0038_ref_033","doi-asserted-by":"crossref","unstructured":"FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee. Int J Gynaecol Obstet 2002; 77: 285-7. doi: 10.1016\/S0020-7292(02)00063-2","DOI":"10.1016\/S0020-7292(02)00063-2"},{"key":"2026071215153105417_j_raon-2022-0038_ref_034","doi-asserted-by":"crossref","unstructured":"Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 2010; 203: 531-9. doi: 10.1016\/j.ajog.2010.06.073","DOI":"10.1016\/j.ajog.2010.06.073"},{"key":"2026071215153105417_j_raon-2022-0038_ref_035","doi-asserted-by":"crossref","unstructured":"Hancock BW, Tidy J. Placental site trophoblastic tumour and epithelioid trophoblastic tumour. Best Pract Res Clin Obstet Gynaecol 2021; 74: 131-48. doi: 10.1016\/j.bpobgyn.2020.10.004","DOI":"10.1016\/j.bpobgyn.2020.10.004"},{"key":"2026071215153105417_j_raon-2022-0038_ref_036","doi-asserted-by":"crossref","unstructured":"Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C. Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): 39-50. doi: 10.1093\/ annonc\/mdt345","DOI":"10.1093\/annonc\/mdt345"},{"key":"2026071215153105417_j_raon-2022-0038_ref_037","doi-asserted-by":"crossref","unstructured":"Biscaro A, Braga A, Berkowitz RS. Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet 2015; 37: 42-51. doi: 10.1590\/SO100-720320140005198","DOI":"10.1590\/SO100-720320140005198"},{"key":"2026071215153105417_j_raon-2022-0038_ref_038","doi-asserted-by":"crossref","unstructured":"Winter MC. Treatment of low-risk gestational trophoblastic neoplasia. Best Pract Res Clin Obstet Gynaecol 2021; 74: 67-80. doi: 10.1016\/j.bpob-gyn.2021.01.006","DOI":"10.1016\/j.bpobgyn.2021.01.006"},{"key":"2026071215153105417_j_raon-2022-0038_ref_039","doi-asserted-by":"crossref","unstructured":"Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol 2009; 112: 654-62. doi: 10.1016\/j.ygy-no.2008.09.005","DOI":"10.1016\/j.ygyno.2008.09.005"},{"key":"2026071215153105417_j_raon-2022-0038_ref_040","doi-asserted-by":"crossref","unstructured":"Braga A, Mora P, Melo AC de, Nogueira-Rodrigues A, Amim-Junior J, Rezende-Filho J, et al. Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide. World J Clin Oncol 2019; 10: 28-37. doi: 10.5306\/wjco.v10.i2.28","DOI":"10.5306\/wjco.v10.i2.28"},{"key":"2026071215153105417_j_raon-2022-0038_ref_041","doi-asserted-by":"crossref","unstructured":"Clark JJ, Slater S, Seckl MJ. Treatment of gestational trophoblastic disease in the 2020s. Curr Opin Obstet Gynecol 2021; 33: 7-12. doi: 10.1097\/ GCO.0000000000000674","DOI":"10.1097\/GCO.0000000000000674"},{"key":"2026071215153105417_j_raon-2022-0038_ref_042","doi-asserted-by":"crossref","unstructured":"Clair KH, Gallegos N, Bristow RE. Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: a case for immune checkpoint salvage therapy in trophoblastic tumors. Gynecol Oncol Rep 2020; 34: 100625. doi: 10.1016\/j.gore.2020.100625","DOI":"10.1016\/j.gore.2020.100625"},{"key":"2026071215153105417_j_raon-2022-0038_ref_043","doi-asserted-by":"crossref","unstructured":"Choi MC, Oh J, Lee C. Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia. Eur J Cancer 2019; 121: 94-7. doi: 10.1016\/j.ejca.2019.08.024","DOI":"10.1016\/j.ejca.2019.08.024"},{"key":"2026071215153105417_j_raon-2022-0038_ref_044","doi-asserted-by":"crossref","unstructured":"Ghorani E, Kaur B, Fisher RA, Short D, Joneborg U, Carlson JW, et al. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet 2017; 390: 2343-5. doi: 10.1016\/S0140-6736(17)32894-5","DOI":"10.1016\/S0140-6736(17)32894-5"},{"key":"2026071215153105417_j_raon-2022-0038_ref_045","doi-asserted-by":"crossref","unstructured":"Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol 2011; 204: 11-8. doi: 10.1016\/j.ajog.2010.06.072","DOI":"10.1016\/j.ajog.2010.06.072"},{"key":"2026071215153105417_j_raon-2022-0038_ref_046","doi-asserted-by":"crossref","unstructured":"di Mattei V, Mazzetti M, Perego G, Rottoli S, Mangili G, Bergamini A, et al. Psychological aspects and fertility issues of GTD. Best Pract Res Clin Obstet Gynaecol 2021; 74: 53-66. doi: 10.1016\/j.bpobgyn.2020.10.007","DOI":"10.1016\/j.bpobgyn.2020.10.007"}],"container-title":["Radiology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/raon-2022-0038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:12:28Z","timestamp":1783901548000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/raon-2022-0038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,10,27]]},"published-print":{"date-parts":[[2022,10,27]]}},"alternative-id":["10.2478\/raon-2022-0038"],"URL":"https:\/\/doi.org\/10.2478\/raon-2022-0038","relation":{},"ISSN":["1581-3207"],"issn-type":[{"value":"1581-3207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]}}}